Industry News External News
Quality, Safety & Pharmacovigilance Articles
Industry News External News
Forget GLP-1 stocks, baldness drugs are Wall Street’s next gold mine - The Japan Times
Google News – Clinical Trials External News
Ascletis Announces First Participant Dosed in a Global Phase III Clinical Program of Once-Daily Oral Small Molecule GLP-1 Receptor Agonist ASC30 for Chronic Weight Management - PR Newswire
Google News – FDA (biotech/pharma) External News
5th Circ. Backs FDA, Pharma Cos. In GLP-1 Shortage Fight - Law360
Google News – FDA (biotech/pharma) External News
5th Circ. Backs FDA, Pharma Cos. In GLP-1 Shortage Fight - Law360
Google News – Pharmaceuticals External News
Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes - Yahoo Finance
Google News – FDA (biotech/pharma) External News
CDMO Quality Oversight How FDA And Pharma Leaders Are Rethinking Data AI And Culture - Bioprocess Online
Google News – Biopharma External News
The role of UV-Vis in biopharma QC - News-Medical
Google News – Biopharma External News
Amylyx’s bet on a GLP-1 blocker pays off - BioPharma Dive
Google News – Healthcare Jobs External News
Healthcare staffing shortages are driving a patient care quality crisis - Axios
Google News – EMA (biotech/pharma) External News
WuXi Biologics Suzhou Center Passes EMA GMP Inspection - Contract Pharma
Google News – EMA (biotech/pharma) External News
Highlights from EMA pharmacovigilance committee meeting - The Pharma Letter
Google News – Digital Health External News
Digital health companies seek lasting edge amid GLP-1 gold rush - TechTarget
Industry News External News
Chief of Quality and Patient Safety receives national recognition from Becker’s Hospital Review - Loma Linda University
Google_site External News